L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1

Clinical trial NCT01733407 · COMPLETED

Trial details

NCT number: NCT01733407
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hereditary Sensory and Autonomic Neuropathy Type I

Start date: 2013-09-01
Primary completion: 2016-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.